Popular

• 

  RestartResume

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

  Medical Industry Feature

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

• 

  RestartResume

  Evidence Builds for Cell-Based Influenza Vaccines

  Medical Industry Feature

  Evidence Builds for Cell-Based Influenza Vaccines

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    Wendy Wright, DNP, FNP-BC, ANP-BC

    Peer

• 

  RestartResume

  Understanding Dual Inhibition of IL-17

  Medical Industry Feature

  Understanding Dual Inhibition of IL-17

  • 

    

    Bret Sohn, MD

    Peer

  • 

    

    Eric Anderson, MD

    Peer

• 

  RestartResume

  Diagnosing IBS-C: From Clinical Clues to Confident Calls

  Clinician's Roundtable

  Diagnosing IBS-C: From Clinical Clues to Confident Calls

  • 

    

    Darren Brenner, MD

    Peer

  • 

    

    Kyle Staller, MD, MPH

    Peer

• 

  RestartResume

  Postpartum Depression: A Common Yet Overlooked Condition

  Medical Industry Feature

  Postpartum Depression: A Common Yet Overlooked Condition

  • 

    

    Sarah Oreck, MD

    Peer

  • 

    

    Brooke Kyle, MD

    Peer

• 

  RestartResume

  Operational Considerations for Bispecific T-Cell Engager Therapies

  Medical Industry Feature

  Operational Considerations for Bispecific T-Cell Engager Therapies

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    David M. Waterhouse, MD, MPH

    Peer

• 

  RestartResume

  Improving Outcomes and Reducing Delays in Orthopedic Surgery

  Medical Industry Feature

  Improving Outcomes and Reducing Delays in Orthopedic Surgery

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    Jesse Pines, MD, MBA, MSCE

    Peer

• 

  RestartResume

  The Impact of Zero in Rheumatology

  Medical Industry Feature

  The Impact of Zero in Rheumatology

  • 

    

    Monica Shah, DO, FACR

    Peer

  • 

    

    Monica Schwartzman, MD, MS

    Peer

  • 

    

    Grace C Wright, MD, PhD, FACR

    Peer

• 

  RestartResume

  Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers

  Medical Industry Feature

  Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers

  • 

    

    Yuval Zabar, MD

    Peer

  • 

    

    Michelle Mielke, PhD

    Peer

  • 

    

    Henrik Zetterberg, MD, PhD

    Peer

• 

  RestartResume

  Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach

  Medical Industry Feature

  Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach

• 

  RestartResume

  The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy

  Medical Industry Feature

  The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy

  • 

    

    Edgar V. Lerma, MD, FACP, FASN, FPSN (Hon)

    Peer

  • 

    

    Luis E. Vélez, MD

    Peer

• 

  RestartResume

  Early Referral in PMR Management and the Impact on Outcomes

  Medical Industry Feature

  Early Referral in PMR Management and the Impact on Outcomes

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Amar Majjhoo, MD

    Peer

  • 

    

    Naureen Alim, MD

    Peer

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  • 

    

    Dana Rizk, MD

    Peer

  • 

    

    Carla Nester, MD

    Peer

  • 

    

    Sanjeev Sethi, MD, PhD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer

• 

  RestartResume

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  Medical Industry Feature

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  • 

    

    Jaimini Patel, PharmD, BCCCP

    Peer

  • 

    

    Sayna Norouzi, MD

    Peer

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  • 

    

    Dana Rizk, MD

    Peer

  • 

    

    Carla Nester, MD

    Peer

  • 

    

    Sanjeev Sethi, MD, PhD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer